Volume 9 Issue 2
Mar.  2018
Turn off MathJax
Article Contents
Du Peng, Zhang Pengjie, Duan Bin, et al. Analysis of risk factors for cerebral apoplexy in the recipients after renal transplantation[J]. ORGAN TRANSPLANTATION, 2018, 9(2): 142-146. doi: 10.3969/j.issn.1674-7445.2018.02.009
Citation: Du Peng, Zhang Pengjie, Duan Bin, et al. Analysis of risk factors for cerebral apoplexy in the recipients after renal transplantation[J]. ORGAN TRANSPLANTATION, 2018, 9(2): 142-146. doi: 10.3969/j.issn.1674-7445.2018.02.009

Analysis of risk factors for cerebral apoplexy in the recipients after renal transplantation

doi: 10.3969/j.issn.1674-7445.2018.02.009
More Information
  • Corresponding author: Du Peng, Email:seasonn@163.com
  • Received Date: 2017-11-23
    Available Online: 2021-01-19
  • Publish Date: 2018-03-15
  •   Objective  To analyze the risk factors for cerebral apoplexy in the recipients after renal transplantation.  Methods  Clinical data of 376 renal transplant recipients who were followed up regularly were retrospectively analyzed. The recipients were divided into cerebral apoplexy group (39 cases) and non-cerebral apoplexy group (337 cases) according to the occurrence of cerebral apoplexy. The risk factors of cerebral apoplexy were analyzed using single factor analysis and COX proportional hazards regression model.  Results  The 376 recipients were followed up for a median duration of 55 months, among whom 39 recipients suffered from cerebral apoplexy, with a cumulative incidence of 10.4%. Single factor analysis indicated that there were significant differences in age ≥40 years old at transplantation, duration of dialysis ≥12 months before transplantation, estimated glomerular filtration rate (eGFR) < 30 mL/(min·1.73m2), incidence of hypertension, diabetes and dyslipidemia between cerebral apoplexy group and non-cerebral apoplexy group (all P < 0.05). Multivariate analysis indicated that the independent risk factors for cerebral apoplexy occurred in the recipients after renal transplantation were age ≥40 years old [hazard ratio (HR) =1.110, 95% confidence interval (CI)=1.067-1.154, P=0.000], duration of dialysis ≥12 months before transplantation (HR=1.044, 95%CI=1.021-1.067, P=0.000) and eGFR < 30 mL/(min·1.73m2) (HR=2.448, 95%CI=1.197-5.005, P=0.014).  Conclusions  The independent risk factors for cerebral apoplexy in the recipients after renal transplantation include age ≥ 40 years old, long duration of dialysis before transplantation and renal insufficiency.

     

  • loading
  • [1]
    FARRUGIA D, CHESHIRE J, BEGAJ I, et al. Death within the first year after kidney transplantation--an observational cohort study[J]. Transpl Int, 2014, 27(3): 262-270. DOI: 10.1111/tri.12218.
    [2]
    陈莉萍, 蔡明, 钱叶勇, 等.肾移植术后患者心血管病危险因素分析[J].解放军医学杂志, 2014, 39(9): 746-750. DOI: 10.11855/j.issn.0577-7402.2014.09.14.

    CHEN LP, CAI M, QIAN YY, et al. Analysis of the risk factors of cardiovascular diseases after renal transplantation[J]. Med J Chin PLA, 2014, 39(9): 746-750. DOI: 10.11855/j.issn.0577-7402.2014.09.14.
    [3]
    LENTINE KL, ROCCA REY LA, KOLLI S, et al. Variations in the risk for cerebrovascular events after kidney transplant compared with experience on the waiting list and after graft failure[J]. Clin J Am Soc Nephrol, 2008, 3(4): 1090-1101. DOI: 10.2215/CJN.03080707.
    [4]
    FERRO CJ, KARIM A, FARRUGIA D, et al. Stroke-related hospitalization and mortality after a kidney allograft: a population-cohort study[J]. Exp Clin Transplant, 2016, 14(1): 50-57. DOI: 10.6002/ect.2015.0071.
    [5]
    黎磊石.中国肾移植手册[M].2版.香港:华夏科学出版社. 2009:155.
    [6]
    中华医学会器官移植分会, 中国医师协会器官移植医师分会. 中国器官移植受者的高血压诊疗指南(2016版)[J]. 器官移植, 2016, 7(4): 255-262. DOI: 10.3969/j.issn.1674-7445.2016.04.002.

    Branch of Organ Transplantation of Chinese Medical Association, Branch of Transplant Physician of Chinese Medical Doctor Association. Guideline on hypertension management of recipients with organ transplantation in China (2016 edition)[J]. Organ Transplant, 2016, 7(4): 255-262. DOI: 10.3969/j.issn.1674-7445.2016.04.002.
    [7]
    中华医学会器官移植分会, 中国医师协会器官移植医师分会. 中国器官移植受者血脂管理指南(2016版)[J]. 器官移植, 2016, 7(4): 243-254. DOI: 10.3969/j.issn.1674-7445.2016.04.001.

    Branch of Organ Transplantation of Chinese Medical Association, Branch of Transplant Physician of Chinese Medical Doctor Association. Guideline on lipid management of recipients with organ transplantation in China (2016 edition)[J]. Organ Transplant, 2016, 7(4): 243-254. DOI: 10.3969/j.issn.1674-7445.2016.04.001.
    [8]
    中华医学会器官移植分会, 中国医师协会器官移植医师分会. 中国器官移植术后糖尿病诊疗指南(2016版)[J]. 器官移植, 2016, 7(6): 407-416. DOI: 10.3969/j.issn.1674-7445.2016.06.001.

    Branch of Organ Transplantation of Chinese Medical Association, Branch of Transplant Physician of Chinese Medical Doctor Association. Guideline on diagnosis and treatment of recipients with diabetes after organ transplantation in China (2016 edition)[J]. Organ Transplant, 2016, 7(6): 407-416. DOI: 10.3969/j.issn.1674-7445.2016.06.001.
    [9]
    中华医学会内分泌学分会. 高尿酸血症和痛风治疗的中国专家共识[J]. 中华内分泌代谢杂志, 2013, 29(11): 913-920. DOI: 10.3760/cma.j.issn.1000-6699.2013.11.001.

    Branch of Endocrinology of Chinese Medical Association. Chinese experts consensus on the treatment of hyperuricemia and gout[J]. Chin J Endocrino Metab, 2013, 29(11): 913-920. DOI: 10.3760/cma.j.issn.1000-6699.2013.11.001.
    [10]
    LEVEY AS, STEVENS LA, SCHMID CH, et al. A new equation to estimate glomerular filtration rate[J]. Ann Intern Med, 2009, 150(9): 604-612. DOI: 10.7326/0003-4819-150-9-200905050-00006.
    [11]
    BENJAMIN EJ, BLAHA MJ, CHIUVE SE, et al. Heart disease and stroke statistics-2017 update: a report from the American Heart Association[J] Circulation, 2017, 135(10): e146-e603. DOI: 10.1161/CIR.0000000000000485.
    [12]
    赵冬.我国人群脑卒中发病率、死亡率的流行病学研究[J].中华流行病学杂志, 2003, 24(3): 236-239. http://www.doc88.com/p-9723388517286.html

    ZHAO D. Epidemiological study on incidence and mortality of stroke in Chinese population[J].Chin J Epidemiol, 2003, 24(3): 236-239. http://www.doc88.com/p-9723388517286.html
    [13]
    FUJⅡ H, JOKI N. Mineral metabolism and cardiovascular disease in CKD[J]. Clin Exp Nephrol, 2017, 21(Suppl 1): 53-63.DOI: 10.1007/s10157-016-1363-8.
    [14]
    ZHOU C, WANG F, WANG JW, et al. Mineral and bone disorder and its association with cardiovascular parameters in Chinese patients with chronic kidney disease[J]. Chin Med J (Engl), 2016, 129(19): 2275-2280. DOI: 10.4103/0366-6999.190678.
    [15]
    MUNTNER P, JUDD SE, MCCLELLAN W, et al. Incidence of stroke symptoms among adults with chronic kidney disease: results from the REasons for Geographic and Racial Differences in Stroke (REGARDS) study[J]. Nephrol Dial Transplant, 2012, 27(1): 166-173. DOI: 10.1093/ndt/gfr218.
    [16]
    FU J, HUANG J, LEI M, et al. Prevalence and impact on stroke in patients receiving maintenance hemodialysis versus peritoneal dialysis: a prospective observational study[J]. PLoS One, 2015, 10(10): e0140887. DOI: 10.1371/journal.pone.0140887.
    [17]
    罗正茂, 刘曼仪, 何凤, 等.维持性透析患者发生脑卒中的危险因素[J].实用医学杂志, 2017, 33(1): 76-79. DOI: 10.3969/j.issn.1006-5725.2017.01.020.

    LUO ZM, LIU MY, HE F, et al. A study on the risk factors for stroke among dialysis patients[J].J Pract Med, 2017, 33(1): 76-79. DOI: 10.3969/j.issn.1006-5725.2017.01.020.
    [18]
    GOTO N, OKADA M, YAMAMOTO T, et al. Association of dialysis duration with outcomes after transplantation in a Japanese cohort[J]. Clin J Am Soc Nephrol, 2016, 11(3): 497-504. DOI: 10.2215/CJN.08670815.
    [19]
    AZZI JR, SAYEGH MH, MALLAT SG. Calcineurin inhibitors: 40 years later, can't live without...[J]. J Immunol, 2013, 191(12): 5785-5791. DOI: 10.4049/jimmunol.1390055.
  • 加载中

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索

    Tables(2)

    Article Metrics

    Article views (153) PDF downloads(19) Cited by()
    Proportional views
    Related

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return